* MEDNAX Inc MD.N MD is expected to show a rise in
quarterly
revenue when it reports results on February 17.
* The Sunrise Florida-based company is expected to report
a
16.1% increase in revenue to $483.828 million from $416.63
million a year ago, according to the mean estimate from 10
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for MEDNAX Inc is for
earnings of 44 cents per share. For the same quarter last year,
the company reported earnings of 25 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 7
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MEDNAX Inc
is
$28.5, about 14.6% above its last closing price of $24.35.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.42 0.42 0.46 Beat 10.6
Jun. 30 2021 0.32 0.32 0.41 Beat 26.4
Mar. 31 2021 0.11 0.13 0.24 Beat 80.9
Dec. 31 2020 0.36 0.36 0.25 Missed -29.8
Sep. 0.39 0.40 0.37 Missed -8.2
30 2020
Jun. 30 2020 0.07 0.09 0.32 Beat 258.7
Mar. 31 2020 0.54 0.54 0.32 Missed -40.8
Dec. 31 2019 0.91 0.90 0.91 Beat 0.9
This summary was machine generated February 15 at 14:20 GMT.
All figures in US dollars unless otherwise stated